Patent · US Active

[1,2,3]triazolo[4,5-D]pyrimidine derivatives

US9056866B2 · kind B2 · utility

6Cited by

0References

46Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Jean-Michel Adam · Rixheim, FR
Caterina Bissantz · Rixheim, FR
Uwe Grether · Weil am Rhein, DE
Atsushi Kimbara · Tokyo, JP
Matthias Nettekoven · Weil am Rhein, DE
Stephan Roever · Inzlingen, DE
Mark Rogers-Evans · Bottmingen, CH

Key dates

Filing date	Apr 11, 2014
Grant date	Jun 16, 2015
Priority date	—
Expiry date	Apr 11, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/107
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I)wherein A, R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.